SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Siobhán Smith, Caroline Jefferies, Role of DNA/RNA sensors and contribution to autoimmunity, Cytokine & Growth Factor Reviews, 2014, 25, 6, 745

    CrossRef

  2. 2
    Stanca A. Birlea, Marc Serota, David A. Norris, The Autoimmune Diseases, 2014,

    CrossRef

  3. 3
    K.N. Kanada, C.W. Schupp, A.W. Armstrong, Association between psoriasis and viral infections in the United States: focusing on hepatitis B, hepatitis C and human immunodeficiency virus, Journal of the European Academy of Dermatology and Venereology, 2013, 27, 10
  4. 4
    Gun-Wook Kim, Seung-Wook Jwa, Margaret Song, Hoon-Soo Kim, Byung-Soo Kim, Moon-Bum Kim, Hyun-Chang Ko, Extensive Psoriasis Induced by Pegylated Interferon Alfa-2a and Ribavirin in the Treatment of Chronic Hepatitis C, Annals of Dermatology, 2013, 25, 4, 479

    CrossRef

  5. 5
    K. Wolk, K. Witte, E. Witte, M. Raftery, G. Kokolakis, S. Philipp, G. Schonrich, K. Warszawska, S. Kirsch, S. Prosch, W. Sterry, H.-D. Volk, R. Sabat, IL-29 Is Produced by TH17 Cells and Mediates the Cutaneous Antiviral Competence in Psoriasis, Science Translational Medicine, 2013, 5, 204, 204ra129

    CrossRef

  6. 6
    M. Afshar, A.D. Martinez, R.L. Gallo, T.R. Hata, Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases, Journal of the European Academy of Dermatology and Venereology, 2013, 27, 6
  7. 7
    Rafael Denadai, Fábio Vieira Teixeira, Flavio Steinwurz, Ricardo Romiti, Rogério Saad-Hossne, Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: A systematic literature review based on 222 cases, Journal of Crohn's and Colitis, 2013, 7, 7, 517

    CrossRef

  8. 8
    Runping Yang, Qiang Zhou, Chunmiao Wen, Jian Hu, Hengjin Li, Ming Zhao, Hua Zhao, Mustard seed (Sinapis Alba Linn) attenuates imiquimod-induced psoriasiform inflammation of BALB/c mice, The Journal of Dermatology, 2013, 40, 7
  9. 9
    Muhammed Sait Dag, Zeynel Abidin Öztürk, Nimet Yılmaz, Hakan Çam, Abdurrahman Kadayıfçı, Peginterferon alfa related psoriasis in a patient with acute hepatitis C and review of the literature, Wiener klinische Wochenschrift, 2013, 125, 17-18, 537

    CrossRef

  10. You have free access to this content10
    Shin MORIZANE, Richard L. GALLO, Antimicrobial peptides in the pathogenesis of psoriasis, The Journal of Dermatology, 2012, 39, 3
  11. 11
    Joshua W. Hagen, Cynthia M. Magro, A. Neil Crowson, Emerging Adverse Cutaneous Drug Reactions, Dermatologic Clinics, 2012, 30, 4, 695

    CrossRef

  12. 12
    H.L. Hébert, F.R. Ali, J. Bowes, C.E.M. Griffiths, A. Barton, R.B. Warren, Genetic susceptibility to psoriasis and psoriatic arthritis: implications for therapy, British Journal of Dermatology, 2012, 166, 3
  13. 13
    Emőke Rácz, Errol P Prens, Dorota Kurek, Marius Kant, Dick de Ridder, Sabine Mourits, Ewout M Baerveldt, Zeliha Ozgur, Wilfred F J van IJcken, Jon D Laman, Frank J Staal, Leslie van der Fits, Effective Treatment of Psoriasis with Narrow-Band UVB Phototherapy Is Linked to Suppression of the IFN and Th17 Pathways, Journal of Investigative Dermatology, 2011, 131, 7, 1547

    CrossRef

  14. 14
    Ricardo Berrios, Jigar Patel, Jack Arbiser, Inflammation, Lifestyle and Chronic Diseases, 2011,

    CrossRef

  15. 15
    Robert Bissonnette, Kim Papp, Catherine Maari, Yihong Yao, Gabriel Robbie, Wendy I. White, Chenxiong Le, Barbara White, A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis, Journal of the American Academy of Dermatology, 2010, 62, 3, 427

    CrossRef

  16. 16
    Karsten W Eriksen, Anders Woetmann, Lone Skov, Thorbjørn Krejsgaard, Lone F Bovin, Mikkel L Hansen, Kirsten Grønbæk, Nils Billestrup, Mogens H Nissen, Carsten Geisler, Mariusz A Wasik, Niels Ødum, Deficient SOCS3 and SHP-1 Expression in Psoriatic T Cells, Journal of Investigative Dermatology, 2010, 130, 6, 1590

    CrossRef

  17. 17
    N. S. Tekin, Y. Ustundag, I. O. Tekin, R. Koca, H. C. Altinyazar, Early administration of ultraviolet treatment is effective in pegylated interferon alpha-induced severe acute exacerbation of psoriasis: a case report and short review of the literature, International Journal of Clinical Practice, 2010, 64, 1
  18. 18
    Guang Yang, Min Wan, Yongsheng Zhang, Luguo Sun, Ran Sun, Dali Hu, Xiaojing Zhou, Li Wang, Xiuli Wu, Liying Wang, Yongli Yu, Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice, Immunology, 2010, 131, 4
  19. 19
    Kabbur Hanumanthappa Basavaraj, Navya Mysore Ashok, Ramesh Rashmi, Thaggikuppe Krishnamurthy Praveen, The role of drugs in the induction and/or exacerbation of psoriasis, International Journal of Dermatology, 2010, 49, 12
  20. 20
    Weedon's Skin Pathology, 2010,

    CrossRef

  21. 21
    Leanne M. Johnson-Huang, N. Scott McNutt, James G. Krueger, Michelle A. Lowes, Cytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin Diseases, Journal of Clinical Immunology, 2009, 29, 3, 247

    CrossRef

  22. 22
    Emőke Rácz, Errol P. Prens, Molecular pathophysiology of psoriasis and molecular targets of antipsoriatic therapy, Expert Reviews in Molecular Medicine, 2009, 11,

    CrossRef

  23. 23
    Yihong Yao, Laura Richman, Brandon W. Higgs, Christopher A. Morehouse, Melissa de los Reyes, Philip Brohawn, Jianliang Zhang, Barbara White, Anthony J. Coyle, Peter A. Kiener, Bahija Jallal, Neutralization of interferon-α/β–inducible genes and downstream effect in a phase I trial of an anti–interferon-α monoclonal antibody in systemic lupus erythematosus, Arthritis & Rheumatism, 2009, 60, 6
  24. 24
    Frank O. Nestle, Daniel H. Kaplan, Jonathan Barker, Psoriasis, New England Journal of Medicine, 2009, 361, 5, 496

    CrossRef

  25. 25
    Fabio O Sánchez, M V Prasad Linga Reddy, Kazuko Sakuraba, Mona Ståhle, Marta E Alarcón-Riquelme, IFN-Regulatory Factor 5 Gene Variants Interact with the Class I MHC Locus in the Swedish Psoriasis Population, Journal of Investigative Dermatology, 2008, 128, 7, 1704

    CrossRef

  26. 26
    Elif Doyuk Kartal, Saygin Nayman Alpat, Ilhan Ozgunes, Gaye Usluer, Adverse effects of high-dose interferon-α-2a treatment for chronic hepatitis B, Advances in Therapy, 2007, 24, 5, 963

    CrossRef

  27. 27
    Brian J. Nickoloff, Hong Xin, Frank O. Nestle, Jian-Zhong Qin, The cytokine and chemokine network in psoriasis, Clinics in Dermatology, 2007, 25, 6, 568

    CrossRef

  28. 28
    Lionel Fry, Barbara S. Baker, Triggering psoriasis: the role of infections and medications, Clinics in Dermatology, 2007, 25, 6, 606

    CrossRef

  29. 29
    Emi Dika, C. Varotti, F. Bardazzi, H. I. Maibach, Drug-Induced Psoriasis: An Evidence-Based Overview and the Introduction of Psoriatic Drug Eruption Probability Score, Cutaneous and Ocular Toxicology, 2006, 25, 1, 1

    CrossRef

  30. 30
    N. Rajan, J. A. A. Langtry, Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas, Clinical and Experimental Dermatology, 2006, 31, 1
  31. 31
    Jacques Banchereau, Virginia Pascual, Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases, Immunity, 2006, 25, 3, 383

    CrossRef

  32. 32
    Joerg Wenzel, Marina Scheler, Julia Proelss, Thomas Bieber, Thomas Tüting, Type I interferon-associated cytotoxic inflammation in lichen planus, Journal of Cutaneous Pathology, 2006, 33, 10
  33. 33
    Brian J. Nickoloff, Seth R. Stevens, What have we learned in dermatology from the biologic therapies?, Journal of the American Academy of Dermatology, 2006, 54, 3, S143

    CrossRef

  34. 34
    Frank O Nestle, Michel Gilliet, Defining Upstream Elements of Psoriasis Pathogenesis: An Emerging Role For Interferon α, Journal of Investigative Dermatology, 2005, 125, 5, xiv

    CrossRef

  35. 35
    Elif Doyuk Kartal, Hasan Colak, Ilhan Özgünes, Gaye Usluer, Exacerbation of Psoriasis due to Peginterferon alpha-2b plus Ribavirin Treatment of Chronic Active Hepatitis C, Chemotherapy, 2005, 51, 2-3, 167

    CrossRef

  36. 36
    Karsten Wessel Eriksen, Paola Lovato, Lone Skov, Thorbjørn Krejsgaard, Keld Kaltoft, Carsten Geisler, Niels Ødum, Increased Sensitivity to Interferon-α in Psoriatic T Cells, Journal of Investigative Dermatology, 2005, 125, 5, 936

    CrossRef

  37. 37
    Deniz Seçkin, Çiçek Durusoy, Sedef Şahin, Concomitant Vitiligo and Psoriasis in a Patient Treated with Interferon Alfa-2a for Chronic Hepatitis B Infection, Pediatric Dermatology, 2004, 21, 5
  38. 38
    Jason K Wu, Greg Siller, Geoff Strutton, Psoriasis induced by topical imiquimod, Australasian Journal of Dermatology, 2004, 45, 1
  39. 39
    Ignazio Olivieri, Carlo Palazzi, Angela Padula, Hepatitis C virus and arthritis, Rheumatic Disease Clinics of North America, 2003, 29, 1, 111

    CrossRef

  40. 40
    Yi-Hsing Chen, Anja P Bieneman, Peter S Creticos, Kristin L Chichester, John T Schroeder, IFN-α inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release, Journal of Allergy and Clinical Immunology, 2003, 112, 5, 944

    CrossRef

  41. 41
    Timothy A. Stewart, Neutralizing interferon alpha as a therapeutic approach to autoimmune diseases, Cytokine & Growth Factor Reviews, 2003, 14, 2, 139

    CrossRef

  42. 42
    James G. Krueger, The immunologic basis for the treatment of psoriasis with new biologic agents, Journal of the American Academy of Dermatology, 2002, 46, 1, 1

    CrossRef

  43. 43
    A Karolina Palucka, Jacques Banchereau, Patrick Blanco, Virginia Pascual, The interplay of dendritic cell subsets in systemic lupus erythematosus, Immunology and Cell Biology, 2002, 80, 5, 484

    CrossRef

  44. 44
    Shinsuke Taki, Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice, Cytokine & Growth Factor Reviews, 2002, 13, 4-5, 379

    CrossRef

  45. 45
    Anuchit Chutaputti, Adverse effects and other safety aspects of the hepatitis C antivirals, Journal of Gastroenterology and Hepatology, 2000, 15,
  46. 46
    Shigeaki Hida, Kouetsu Ogasawara, Kojiro Sato, Masaaki Abe, Hiroshi Takayanagi, Taeko Yokochi, Takeo Sato, Sachiko Hirose, Toshikazu Shirai, Shinsuke Taki, Tadatsugu Taniguchi, CD8+ T Cell–Mediated Skin Disease in Mice Lacking IRF-2, the Transcriptional Attenuator of Interferon-α/β Signaling, Immunity, 2000, 13, 5, 643

    CrossRef

  47. 47
    F.L. Dumoulin, L. Leifeld, T. Sauerbruch, U. Spengler, Autoimmunity induced by interferon-α therapy for chronic viral hepatitis, Biomedicine & Pharmacotherapy, 1999, 53, 5-6, 242

    CrossRef

  48. 48
    Dimitrios Vassilopoulos, Charles Camisa, Robert M. Strauss, SELECTED DRUG COMPLICATIONS AND TREATMENT CONFLICTS IN THE PRESENCE OF COEXISTENT DISEASES, Rheumatic Disease Clinics of North America, 1999, 25, 3, 745

    CrossRef

  49. 49
    Sara K. Ward, Henry H. Roenigk, Kenneth B. Gordon, DERMATOLOGIC MANIFESTATIONS OF GASTROINTESTINAL DISORDERS, Gastroenterology Clinics of North America, 1998, 27, 3, 615

    CrossRef

  50. 50
    Nikolai Tsankov, Jana Kazandjieva, Kossara Drenovska, Drugs in Exacerbation and Provocation of Psoriasis, Clinics in Dermatology, 1998, 16, 3, 333

    CrossRef

  51. 51
    Franco Rongioletti, Alfredo Rebora, Worsening of lichen myxedematosus during interferon alfa-2a therapy for chronic active hepatitis C, Journal of the American Academy of Dermatology, 1998, 38, 5, 760

    CrossRef

  52. 52
    J.A. SNOWDEN, D.C. HEATON, Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity, British Journal of Dermatology, 1997, 137, 1, 130

    CrossRef

  53. 53
    Jörg Fritzsch, Jürgen Krug, Hans-Jürgen Heberling, Interferontherapie und Autoimmunität, Medizinische Klinik, 1997, 92, 5, 265

    CrossRef

  54. 54
    F. Lombardini, E. Taglione, L. Riente, G. Pasero, Psoriatic Arthritis with Spinal Involvement in a Patient Receiving Alpha-interferon for Chronic Hepatitis C, Scandinavian Journal of Rheumatology, 1997, 26, 1, 58

    CrossRef

  55. 55
    Ronald Prussick, Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy, Seminars in Cutaneous Medicine and Surgery, 1996, 15, 4, 267

    CrossRef

  56. 56
    O. Servitje, X. Bordas, D. Serón, A. Vidaller, A. Moreno, N. Curcó, G. Sais, J. Peyrí, Changes in T-cell phenotype and adhesion molecules expression in psoriatic lesions after low-dose cyclosporin therapy, Journal of Cutaneous Pathology, 1996, 23, 5
  57. 57
    Maureen M. Jonas, Hepatitis C virus infection: clinical aspects and treatment with interferon alfa, Clinical Therapeutics, 1996, 18, 110

    CrossRef

  58. 58
    Maureen M. Jonas, Interferon-α for Viral Hepatitis, Journal of Pediatric Gastroenterology &amp Nutrition, 1996, 23, 2, 93

    CrossRef

  59. 59
    Harvey Rotstein, Psoriasis: Changing clinical patterns, Australasian Journal of Dermatology, 1996, 37,
  60. 60
    Jonathan T Wolfe, Anjali Singh, Stuart R Lessin, Christine Jaworsky, Alain H Rook, De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma, Journal of the American Academy of Dermatology, 1995, 32, 5, 887

    CrossRef

  61. 61
    Masahide Yoshikawa, Hiroshi Fukui, Tadasu Tsujii, Immunological Adverse Effects of Interferon Treatment, Clinical Immunotherapeutics, 1995, 4, 5, 361

    CrossRef

  62. 62
    Norah Terrault, S. Victor Feinman, Interferons for viral hepatitis, Transfusion Medicine Reviews, 1995, 9, 1, 29

    CrossRef

  63. 63
    Emilio D'Amico, Marino Paroli, Vincenzina Fratelli, Carlo Palazzi, Vincenzo Barnaba, Francesco Callea, Giuseppe Consoli, Primary biliary cirrhosis induced by interferon-α therapy for hepatitis C virus infection, Digestive Diseases and Sciences, 1995, 40, 10, 2113

    CrossRef

  64. 64
    Ronald Prussick, Sandra Knowles, Neil H. Shear, Cutaneous drug reactions, Current Problems in Dermatology, 1994, 6, 3, 83

    CrossRef

  65. 65
    Kathleen J. Smith, Henry G. Skelton, Josef Yeager, Rebecca Ledsky, William McCarthy, Donald Baxter, Kenneth F. Wagner, Cutaneous findings in HIV-1-positive patients: A 42-month prospective study, Journal of the American Academy of Dermatology, 1994, 31, 5, 746

    CrossRef

  66. 66
    PETER SCHMID, PETER ITIN, DAVID COX, GARY K. McMASTER, MICHEL A. HORISBERGER, The Type I Interferon System Is Locally Activated in Psoriatic Lesions, Journal of Interferon Research, 1994, 14, 5, 229

    CrossRef

  67. 67
    Mark G. Cleveland, Susan B. Mallory, Incomplete Reiter's syndrome induced by systemic interferon α treatment, Journal of the American Academy of Dermatology, 1993, 29, 5, 788

    CrossRef

  68. 68
    J. Dupont, J. Orgiazzi, A. Burger, Maladies auto-immunes et traitement par l'IFN-α: revue de la littérature à propos d'un cas d'hyperthyroïdie, La Revue de Médecine Interne, 1993, 14, 2, 93

    CrossRef

  69. 69
    Guy F. Webster, Pustular drug reactions, Clinics in Dermatology, 1993, 11, 4, 541

    CrossRef

  70. 70
    Alexander Kapp, The role of cytokines in the psoriatic inflammation, Journal of Dermatological Science, 1993, 5, 3, 133

    CrossRef

  71. 71
    P. Reiss, M.D. de Jong, 1993,

    CrossRef

  72. 72
    Kathryn T. Ciccolini, Katharina C. Kaehler, Mario E. Lacouture, Axel Hauschild, Skin Toxicities due to Biotherapy,